Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6/2 Mouse Model of Huntington's Disease
Caroline L. Benn, Rachel Butler, Lydia Mariner et al. · 2009
Read Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6/2 Mouse Model of Huntington's Disease by Caroline L. Benn, Rachel Butler, Lydia Mariner et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005747.txt.
Description
Caroline Benn and co-authors tested in 2009 whether lowering one gene's activity eases Huntington's disease in mice. Huntington's is a fatal inherited brain disease with no treatment that slows it. Faulty gene control inside cells is part of the damage, so enzymes that tune genes are drug targets.
The team reduced HDAC7, one such tuning enzyme, in the R6/2 mouse model. The disease course did not improve. A clear negative result still guides the field: effort can shift to other HDAC types. The study shows why each candidate must be tested alone, not assumed to help as a class.
Catalog record
| CREATOR | Caroline L. Benn, Rachel Butler, Lydia Mariner et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 46 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005747